Nanollose (ASX:NC6) entered into an AU$200,000 research and development loan facility with Asymmetric Innovative Finance, according to a Wednesday filing with the Australian bourse.
The loan facility, secured by the biomaterials company's expected R&D tax rebate for FY24, has an annual interest rate of 16%. The funds from this loan facility have been received, the filing said.
Shares of Nanollose plunged almost 10% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments